Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPOWER: ondansetron with metoclopramide for nausea and vomiting in pregnancy
2017-001651-31Phase 3Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ondansetron and metoclopramide in nausea and vomiting of pregnancy (NVP) (4 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Treatment failure. Started Oct 2017; status: completed.
02
Drugs
ondansetronmetoclopramide
03
Conditions
nausea and vomiting of pregnancy (NVP)
Beyond the preview
Go deeper on 2017-001651-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001651-31.